These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 10845721)
1. Tumor cells expressing membrane-bound form of IL-4 induce antitumor immunity. Kim YS; Sonn CH; Paik SG; Bothwell AL Gene Ther; 2000 May; 7(10):837-43. PubMed ID: 10845721 [TBL] [Abstract][Full Text] [Related]
2. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
3. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo. Okada H; Attanucci J; Giezeman-Smits KM; Brissette-Storkus C; Fellows WK; Gambotto A; Pollack LF; Pogue-Geile K; Lotze MT; Bozik ME; Chambers WH Cancer Res; 2001 Mar; 61(6):2625-31. PubMed ID: 11289140 [TBL] [Abstract][Full Text] [Related]
9. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors. Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647 [TBL] [Abstract][Full Text] [Related]
10. Enhanced HER-2/neu-specific antitumor immunity by cotransduction of mouse dendritic cells with two genes encoding HER-2/neu and alpha tumor necrosis factor. Chen Z; Huang H; Chang T; Carlsen S; Saxena A; Marr R; Xing Z; Xiang J Cancer Gene Ther; 2002 Sep; 9(9):778-86. PubMed ID: 12189528 [TBL] [Abstract][Full Text] [Related]
11. Intratumoral delivery of dendritic cells engineered to secrete both interleukin (IL)-12 and IL-18 effectively treats local and distant disease in association with broadly reactive Tc1-type immunity. Tatsumi T; Huang J; Gooding WE; Gambotto A; Robbins PD; Vujanovic NL; Alber SM; Watkins SC; Okada H; Storkus WJ Cancer Res; 2003 Oct; 63(19):6378-86. PubMed ID: 14559827 [TBL] [Abstract][Full Text] [Related]
12. Co-modification of IL-2-TNF alpha fusion gene and B7.1 gene to murine breast tumor cells leads to improved tumor rejection and vaccine effect. Liu X; Zhang L; Zhang M; Ma Y; Xu X; Cai Y Chin Med J (Engl); 2000 Feb; 113(2):167-71. PubMed ID: 11775545 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic antitumor response to cervical cancer in mice immunized with U14 vaccines transfected with costimulatory B7 gene. Tao G; Hu J; Zou H; Lin Q; Liu F; Wu Y; Sun Q Chin Med J (Engl); 2001 Jun; 114(6):623-7. PubMed ID: 11780440 [TBL] [Abstract][Full Text] [Related]
14. Local tumor irradiation augments the antitumor effect of cytokine-producing autologous cancer cell vaccines in a murine glioma model. Lumniczky K; Desaknai S; Mangel L; Szende B; Hamada H; Hidvegi EJ; Safrany G Cancer Gene Ther; 2002 Jan; 9(1):44-52. PubMed ID: 11916244 [TBL] [Abstract][Full Text] [Related]
15. Complete tumor prevention by engineered tumor cell vaccines employing nonviral vectors. Moret-Tatay I; Díaz J; Marco FM; Crespo A; Aliño SF Cancer Gene Ther; 2003 Dec; 10(12):887-97. PubMed ID: 14712315 [TBL] [Abstract][Full Text] [Related]
16. Tumor cells with B7.1 and transmembrane anchored staphylococcal enterotoxin A generate effective antitumor immunity. Si SY; Hu PZ; Huang YY; Ye J; Huang Y; Li ZS; Ge W; Li X; Qu P; Zhang XM; Sui YF Biochem Biophys Res Commun; 2006 Aug; 347(1):208-14. PubMed ID: 16814254 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-4 gene transduced tumor cells promote a potent tumor-specific Th1-type response in cooperation with interferon-alpha transduction. Eguchi J; Hiroishi K; Ishii S; Baba T; Matsumura T; Hiraide A; Okada H; Imawari M Gene Ther; 2005 May; 12(9):733-41. PubMed ID: 15772692 [TBL] [Abstract][Full Text] [Related]
18. Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine. De Giovanni C; Nicoletti G; Landuzzi L; Astolfi A; Croci S; Comes A; Ferrini S; Meazza R; Iezzi M; Di Carlo E; Musiani P; Cavallo F; Nanni P; Lollini PL Cancer Res; 2004 Jun; 64(11):4001-9. PubMed ID: 15173014 [TBL] [Abstract][Full Text] [Related]
19. Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells. Suzuki T; Fukuhara T; Tanaka M; Nakamura A; Akiyama K; Sakakibara T; Koinuma D; Kikuchi T; Tazawa R; Maemondo M; Hagiwara K; Saijo Y; Nukiwa T Clin Cancer Res; 2005 Jan; 11(1):58-66. PubMed ID: 15671528 [TBL] [Abstract][Full Text] [Related]
20. Novel membrane-bound GM-CSF vaccines for the treatment of cancer: generation and evaluation of mbGM-CSF mouse B16F10 melanoma cell vaccine. Yei S; Bartholomew RM; Pezzoli P; Gutierrez A; Gouveia E; Bassett D; Soo Hoo W; Carlo DJ Gene Ther; 2002 Oct; 9(19):1302-11. PubMed ID: 12224013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]